GRND vs HCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

GRND

56.9
AI Score
VS
GRND Wins

HCAT

49.5
AI Score

Investment Advisor Scores

GRND

57score
Recommendation
HOLD

HCAT

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GRND HCAT Winner
Forward P/E 0 10 Tie
PEG Ratio 0 0 Tie
Revenue Growth 32.5% -12.7% GRND
Earnings Growth 25.0% 0.0% GRND
Tradestie Score 56.9/100 49.5/100 GRND
Profit Margin 18.8% -90.6% GRND
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GRND 1M: -13.8% · 3M: -11.6% HCAT 1M: -2.9% · 3M: -21.4%

Current Technical Phase

GRND

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $13.68

HCAT

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -6.8%) with fading momentum, RSI 43

RSI (14): 42.7 · Price: $1.69

Fundamentals Snapshot

Metric GRND HCAT
Market Cap — —
Forward P/E 17.8 225.3
Trailing P/E 29.4 —
Revenue (TTM) — —
Revenue Growth 0.3% -0.1%
Gross Margin 0.7% 0.5%
Operating Margin 0.2% -0.1%
EPS 0.48 -3.71
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GRND is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.